ABBEY ELVERD: Open Payments
NPI 1134855885 · SODDY DAISY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 48 payments from 12 companies in 2025. Trend: 2023 $860 · 2024 $1,340 · 2025 $941
Food & beverage: $941
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $164 |
| ABBVIE INC. | 9 | $140 |
| Otsuka America Pharmaceutical, Inc. | 6 | $125 |
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| Axsome Therapeutics, Inc. | 3 | $78 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Lilly USA, LLC | 3 | $56 |
| Lundbeck LLC | 2 | $53 |
| GlaxoSmithKline, LLC. | 2 | $44 |
Products named: REXULTI, VRAYLAR, Auvelity, FANAPT, Ozempic, CAPLYTA, AIRSUPRA, Wegovy.
Industry payments across TN — which companies pay providers there.
